PAM Antibodies

Santa Cruz Biotechnology features a diverse variety of PAM Antibodies for detecting and analyzing PAM (Peptidylglycine Alpha-Amidating Monooxygenase). Monoclonal PAM Antibodies excel in multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PAM plays a crucial role in the post-translational modification of neuropeptides, facilitating their conversion into biologically active forms. PAM (Peptidylglycine Alpha-Amidating Monooxygenase) is essential for proper nervous system functioning and influences various physiological processes, including pain modulation and stress response. Research focused on PAM can provide valuable insights into neurobiological disorders and potential therapeutic targets. Investigating PAM expression patterns and activity levels helps advance understanding of neural signaling pathways and their regulation. Studying PAM mechanisms contributes to knowledge about neuropeptide processing and its impact on cellular communication. Santa Cruz Biotechnology monoclonal PAM Antibodies support researchers worldwide in advancing neuroscience research and developing innovative therapeutic strategies.